|
It is interesting to see that the 70 gene signature test can identify good prognosis Her2+ patients, as the Oncotype Dx generally classifies all of us as "high risk." I think it has to do with the use of a validation group made up of patients taking only tamoxifen for the Oncotype test.
Hopeful
|